novo nordisk's wegovy reduces cardiovascular risk more than lilly's tirzepatide Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug Novo Nordisk is slashing GLP-1
Pay in 4 interest-free payments of $5.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24



























